Press Releases

Veterinary Antimicrobial Susceptibility Testing Market Size to Worth Around USD 62.78 Bn by 2030

Share This Article

The global Veterinary Antimicrobial Susceptibility Testing market size is expected to reach USD 62.78 billion by 2030 and is expected to expand at a CAGR of 10.1% from 2021 to 2030.

Download Exclusive Sample of Report@ https://www.visionresearchreports.com/report/sample/38477

Growth Factors

The key factors fueling the market growth include growing demand for livestock products and increasing government initiatives. Government initiatives mandating safe healthcare practices for livestock and companion animals are fueling the growth of the market. Several governments worldwide are focused on protecting animals and humans from antibiotics resistance. In addition, efforts are being taken to increase awareness about the reduction of usage of antimicrobials in food animals. The WHO is collaborating with the World Organization for Animal Health (OIE), Food and Agriculture Organization (FAO), national ministries of health, World Bank, and UNSIC to take major actions regarding antimicrobial resistance, which is further propelling the market growth. 

Report Coverage

Report Details
Market Size US$ 62.78 billion by 2030
Growth Rate CAGR of 10.1% From 2021 to 2030
Base Year 2020
Historic Data 2017 to 2020
Forecast Period 2021 to 2030
Segments Covered Animal type, Product, End-use
Regional Scope North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Companies Mentioned BioMérieux SA; Becton, Dickinson and Company; Synbiosis; Thermo Fisher Scientific; Bruker Corporation; Danaher Corporation; Condalab; Bioguard Corporation; LiofilchemS.r.l.; HiMedia Laboratories; Bio-Rad Laboratories; Neogen Corporation

Report Highlights

Livestock animals, also known as production animals, held the largest share of over 64.0% in 2020. This can be attributed to the growing consumption of animal proteins and stringent regulations regarding the usage of antibiotics in food animals.

Automated AST instruments held the largest revenue share of over 41.0% in 2020. The growth can be attributed to the increasing adoption of these instruments and their higher cost as compared to other methods. Moreover, these instruments have improved the turnaround time and time of identification, which is propelling the growth. The instruments have advanced computer software to interpret susceptibility patterns for each organism and give error-free results.

Veterinary reference labs held the largest revenue share of over 55.0% in 2020 owing to the most number of testing of samples done under these facilities. These laboratories use diagnostic kits available in the market to serve pet owners, farm owners, government-related programs, or research collaborations.

Asia Pacific held the largest share of over 33.0% in 2020 owing to the presence of a large livestock population in this region. Increasing demand for milk and animal-based protein and government initiatives are propelling the market growth in this region.

Key Players

  • BioMérieux SA
  • Becton, Dickinson and Company
  • Synbiosis
  • Thermo Fisher Scientific
  • Bruker Corporation
  • Danaher Corporation
  • Condalab
  • Bioguard Corporation
  • Liofilchem S.r.l.
  • HiMedia Laboratories
  • Bio-Rad Laboratories
  • Neogen Corporation

Market Segmentation

  • Animal Type
    • Livestock Animals
      • Cattle
      • Poultry
      • Pigs
      • Others
    • Companion Animals
      • Cats
      • Dogs
      • Horses
      • Others
  • Product
    • Disks & Plates
    • Culture Media
    • Accessories & Consumables
    • Automated AST Instruments
  • End-use
    • Veterinary Reference Lab
    • Veterinary Research Institutes
    • Others
  • Regional
    • North America
      • U.S.
      • Canada
    • Europe
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
    • Asia Pacific
      • China
      • India
      • Japan
    • Latin America
      • Brazil
      • Mexico
    • MEA
      • South Africa

Buy this Research Report study@ https://www.visionresearchreports.com/report/cart/38477

Reasons to Purchase this Report:

– Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
– Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
– Market value USD Million and volume Units Million data for each segment and sub-segment
– Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
– Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players

Table of Contents

Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Distribution Channel Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global Veterinary Antimicrobial Susceptibility Testing Market, By Capacitor

7.1.  Veterinary Antimicrobial Susceptibility Testing Market, by Capacitor, 2021-2030

7.1.1.    Livestock Animals

7.1.1.1.        Market Revenue and Forecast (2017-2030)

7.1.2.    Companion Animals

7.1.2.1.        Market Revenue and Forecast (2017-2030)

Chapter 8.  Global Veterinary Antimicrobial Susceptibility Testing Market, By Product

8.1.  Veterinary Antimicrobial Susceptibility Testing Market, by Product, 2021-2030

8.1.1.    Disks & Plates

8.1.1.1.        Market Revenue and Forecast (2017-2030)

8.1.2.    Culture Media

8.1.2.1.        Market Revenue and Forecast (2017-2030)

8.1.3.    Accessories & Consumables

8.1.3.1.        Market Revenue and Forecast (2017-2030)

8.1.4.    Automated AST Instruments

8.1.4.1.        Market Revenue and Forecast (2017-2030)

Chapter 9.  Global Veterinary Antimicrobial Susceptibility Testing Market, By End User

9.1.  Veterinary Antimicrobial Susceptibility Testing Market, by End User, 2021-2030

9.1.1.    Veterinary Reference Lab

9.1.1.1.        Market Revenue and Forecast (2017-2030)

9.1.2.    Veterinary Research Institutes

9.1.2.1.        Market Revenue and Forecast (2017-2030)

9.1.3.    Others

9.1.3.1.        Market Revenue and Forecast (2017-2030)

Chapter 10.      Global Veterinary Antimicrobial Susceptibility Testing Market, Regional Estimates and Trend Forecast

10.1.        North America

10.1.1.  Market Revenue and Forecast, by Capacitor (2017-2030)

10.1.2.  Market Revenue and Forecast, by Product (2017-2030)

10.1.3.  Market Revenue and Forecast, by End User (2017-2030)

10.1.4.  U.S.

10.1.4.1.      Market Revenue and Forecast, by Capacitor (2017-2030)

10.1.4.2.      Market Revenue and Forecast, by Product (2017-2030)

10.1.4.3.      Market Revenue and Forecast, by End User (2017-2030)

10.1.5.  Rest of North America

10.1.5.1.      Market Revenue and Forecast, by Capacitor (2017-2030)

10.1.5.2.      Market Revenue and Forecast, by Product (2017-2030)

10.1.5.3.      Market Revenue and Forecast, by End User (2017-2030)

10.2.        Europe

10.2.1.  Market Revenue and Forecast, by Capacitor (2017-2030)

10.2.2.  Market Revenue and Forecast, by Product (2017-2030)

10.2.3.  Market Revenue and Forecast, by End User (2017-2030)

10.2.4.  UK

10.2.4.1.      Market Revenue and Forecast, by Capacitor (2017-2030)

10.2.4.2.      Market Revenue and Forecast, by Product (2017-2030)

10.2.4.3.      Market Revenue and Forecast, by End User (2017-2030)

10.2.5.  Germany

10.2.5.1.      Market Revenue and Forecast, by Capacitor (2017-2030)

10.2.5.2.      Market Revenue and Forecast, by Product (2017-2030)

10.2.5.3.      Market Revenue and Forecast, by End User (2017-2030)

10.2.6.  France

10.2.6.1.      Market Revenue and Forecast, by Capacitor (2017-2030)

10.2.6.2.      Market Revenue and Forecast, by Product (2017-2030)

10.2.6.3.      Market Revenue and Forecast, by End User (2017-2030)

10.2.7.  Rest of Europe

10.2.7.1.      Market Revenue and Forecast, by Capacitor (2017-2030)

10.2.7.2.      Market Revenue and Forecast, by Product (2017-2030)

10.2.7.3.      Market Revenue and Forecast, by End User (2017-2030)

10.3.        APAC

10.3.1.  Market Revenue and Forecast, by Capacitor (2017-2030)

10.3.2.  Market Revenue and Forecast, by Product (2017-2030)

10.3.3.  Market Revenue and Forecast, by End User (2017-2030)

10.3.4.  India

10.3.4.1.      Market Revenue and Forecast, by Capacitor (2017-2030)

10.3.4.2.      Market Revenue and Forecast, by Product (2017-2030)

10.3.4.3.      Market Revenue and Forecast, by End User (2017-2030)

10.3.5.  China

10.3.5.1.      Market Revenue and Forecast, by Capacitor (2017-2030)

10.3.5.2.      Market Revenue and Forecast, by Product (2017-2030)

10.3.5.3.      Market Revenue and Forecast, by End User (2017-2030)

10.3.6.  Japan

10.3.6.1.      Market Revenue and Forecast, by Capacitor (2017-2030)

10.3.6.2.      Market Revenue and Forecast, by Product (2017-2030)

10.3.6.3.      Market Revenue and Forecast, by End User (2017-2030)

10.3.7.  Rest of APAC

10.3.7.1.      Market Revenue and Forecast, by Capacitor (2017-2030)

10.3.7.2.      Market Revenue and Forecast, by Product (2017-2030)

10.3.7.3.      Market Revenue and Forecast, by End User (2017-2030)

10.4.        MEA

10.4.1.  Market Revenue and Forecast, by Capacitor (2017-2030)

10.4.2.  Market Revenue and Forecast, by Product (2017-2030)

10.4.3.  Market Revenue and Forecast, by End User (2017-2030)

10.4.4.  GCC

10.4.4.1.      Market Revenue and Forecast, by Capacitor (2017-2030)

10.4.4.2.      Market Revenue and Forecast, by Product (2017-2030)

10.4.4.3.      Market Revenue and Forecast, by End User (2017-2030)

10.4.5.  North Africa

10.4.5.1.      Market Revenue and Forecast, by Capacitor (2017-2030)

10.4.5.2.      Market Revenue and Forecast, by Product (2017-2030)

10.4.5.3.      Market Revenue and Forecast, by End User (2017-2030)

10.4.6.  South Africa

10.4.6.1.      Market Revenue and Forecast, by Capacitor (2017-2030)

10.4.6.2.      Market Revenue and Forecast, by Product (2017-2030)

10.4.6.3.      Market Revenue and Forecast, by End User (2017-2030)

10.4.7.  Rest of MEA

10.4.7.1.      Market Revenue and Forecast, by Capacitor (2017-2030)

10.4.7.2.      Market Revenue and Forecast, by Product (2017-2030)

10.4.7.3.      Market Revenue and Forecast, by End User (2017-2030)

10.5.        Latin America

10.5.1.  Market Revenue and Forecast, by Capacitor (2017-2030)

10.5.2.  Market Revenue and Forecast, by Product (2017-2030)

10.5.3.  Market Revenue and Forecast, by End User (2017-2030)

10.5.4.  Brazil

10.5.4.1.      Market Revenue and Forecast, by Capacitor (2017-2030)

10.5.4.2.      Market Revenue and Forecast, by Product (2017-2030)

10.5.4.3.      Market Revenue and Forecast, by End User (2017-2030)

10.5.5.  Rest of LATAM

10.5.5.1.      Market Revenue and Forecast, by Capacitor (2017-2030)

10.5.5.2.      Market Revenue and Forecast, by Product (2017-2030)

10.5.5.3.      Market Revenue and Forecast, by End User (2017-2030)

Chapter 11.  Company Profiles

11.1.              Becton, Dickinson and Company

11.1.1.  Company Overview

11.1.2.  Product Offerings

11.1.3.  Financial Performance

11.1.4.  Recent Initiatives

11.2.              Synbiosis

11.2.1.  Company Overview

11.2.2.  Product Offerings

11.2.3.  Financial Performance

11.2.4.  Recent Initiatives

11.3.              Thermo Fisher Scientific

11.3.1.  Company Overview

11.3.2.  Product Offerings

11.3.3.  Financial Performance

11.3.4.  Recent Initiatives

11.4.              Bruker Corporation

11.4.1.  Company Overview

11.4.2.  Product Offerings

11.4.3.  Financial Performance

11.4.4.  Recent Initiatives

11.5.              Danaher Corporation

11.5.1.  Company Overview

11.5.2.  Product Offerings

11.5.3.  Financial Performance

11.5.4.  Recent Initiatives

11.6.              Condalab

11.6.1.  Company Overview

11.6.2.  Product Offerings

11.6.3.  Financial Performance

11.6.4.  Recent Initiatives

11.7.              Bioguard Corporation

11.7.1.  Company Overview

11.7.2.  Product Offerings

11.7.3.  Financial Performance

11.7.4.  Recent Initiatives

11.8.              Liofilchem S.r.l.

11.8.1.  Company Overview

11.8.2.  Product Offerings

11.8.3.  Financial Performance

11.8.4.  Recent Initiatives

11.9.              HiMedia Laboratories

11.9.1.  Company Overview

11.9.2.  Product Offerings

11.9.3.  Financial Performance

11.9.4.  Recent Initiatives

11.10.           Bio-Rad Laboratories

11.10.1.               Company Overview

11.10.2.               Product Offerings

11.10.3.               Financial Performance

11.10.4.               Recent Initiatives

11.11.           Neogen Corporation

11.11.1.               Company Overview

11.11.2.               Product Offerings

11.11.3.               Financial Performance

11.11.4.               Recent Initiatives

Chapter 12.  Research Methodology

12.1.              Primary Research

12.2.              Secondary Research

12.3.              Assumptions

Chapter 13.  Appendix

13.1.              About Us

13.2.              Glossary of Terms

Buy this Research Report study@ https://www.visionresearchreports.com/report/cart/38477

Contact Us:

Vision Research Reports

Call: +1 9197 992 333

Email: sales@visionresearchreports.com

Show More

Related Articles

Back to top button